Amanote Research
Register
Sign In
BCL6-Driven Lymphoma Is Dependent on LSD1 Corepression
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2018-216
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
December 21, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Dissecting LSD1-Dependent Neuronal Maturation in the Olfactory Epithelium
Journal of Comparative Neurology
Neuroscience
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC to Provide Insight Into Small Molecule Targeting of BCL6
ACS Chemical Biology
Biochemistry
Medicine
Molecular Medicine
B-Cell CLL/lymphoma 6 (BCL6); Heat Shock Protein 90 (Hsp90)
Science-Business eXchange
BCL6 Gene Amplification/3q27 Gain Is Associated With Unique Clinicopathological Characteristics Among Follicular Lymphoma Without BCL2 Gene Translocation
Modern Pathology
Forensic Medicine
Pathology
Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis
Cells
Prolactin Inhibits BCL6 Expression in Breast Cancer Through a Stat5a-Dependent Mechanism
Cancer Research
Cancer Research
Oncology
LSD1 (KDM1A)-independent Effects of the LSD1 Inhibitor SP2509 in Cancer Cells
British Journal of Haematology
Hematology
KRAS-Driven Cancers Are Dependent on METTL13-Mediated eEF1A Methylation
Cancer Discovery
Oncology
MYC-Driven Tumors Are Dependent on CDK9-Mediated Transcription Elongation
Cancer Discovery
Oncology